20D0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cidara Therapeutics Inc

Watchlist Manager

Watchlist

Price: 183 EUR

Market Cap: €5.8B

	Cidara Therapeutics Inc F:20D0	US
I	Illinois Tool Works Inc XMUN:ILT	US
	Hooker Furnishings Corp NASDAQ:HOFT	US
	Vale SA NYSE:VALE	BR
L	Lynas Rare Earths Ltd LSE:0A2N	MY
A	Abbott Laboratories F:ABL	US
	ProPetro Holding Corp F:2PG	US
R	Relx PLC XMUN:RDED	UK
N	Nutanix Inc F:0NU	US
T	TAG Immobilien AG XMUN:TEG	DE
	Blackstone Mortgage Trust Inc NYSE:BXMT	US
	Fortec Elektronik AG F:FEV	DE
	Cohort PLC LSE:CHRT	UK
K	Kohls Corp DUS:KHP	US
R	RTL Group SA XBER:RRTL	LU
W	Wendel SE SWB:WIS	FR
M	Molson Coors Beverage Co F:NY7	US

Profitability Summary

Cidara Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

30%

Low Operating Margin

Negative 3Y Average Operating Margin

-8 933%

Low Net Margin

Negative 3Y Average Net Margin

-9 358%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-9 809%

Negative ROE

-69%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-379%

Declining ROIC

-92% > -238%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.